Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.840
+0.160 (3.42%)
At close: Jan 27, 2026, 4:00 PM EST
4.930
+0.090 (1.86%)
After-hours: Jan 27, 2026, 7:53 PM EST
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $101.27 million as of January 27, 2026. Its market cap has decreased by -0.14% in one year.
Market Cap
101.27M
Enterprise Value
73.14M
1-Year Change
-0.14%
Ranking
Category
Stock Price
$4.84
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $101.27M, an increase of 755.56%. That is a compound annual growth rate of 100.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 97.93M | -19.31% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 103.74M |
| Agenus | 103.73M |
| Dogwood Therapeutics | 102.98M |
| Korro Bio | 102.46M |
| MindWalk Holdings | 101.95M |
| Vivani Medical | 101.40M |
| Pyxis Oncology | 100.25M |
| Anixa Biosciences | 100.13M |